ロード中...

Immune Checkpoint Inhibitors in Non‐Small Cell Lung Cancer

Historically, lung cancer was long considered a poorly immunogenic malignancy. In recent years, however, immune checkpoint inhibitors have emerged as promising therapeutic agents in non‐small cell lung cancer (NSCLC). To date, the best characterized and most therapeutically relevant immune checkpoin...

詳細記述

保存先:
書誌詳細
出版年:Oncologist
主要な著者: Herzberg, Benjamin, Campo, Meghan J., Gainor, Justin F.
フォーマット: Artigo
言語:Inglês
出版事項: Wiley-Blackwell 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5313266/
https://ncbi.nlm.nih.gov/pubmed/27534574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0189
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!